Table 3.
Incidence of adverse events
| Event | AS group (n = 62) | SOX group (n = 81) | p-Value | ||
|---|---|---|---|---|---|
| Grade1/2 | Grade3/4 | Grade1/2 | Grade3/4 | ||
| Leukocytopenia | 3 (4.84%) | 3 (4.84%) | 2 (2.47%) | N/A | 0.0800 |
| Anemia | 2 (3.23%) | N/A | 1 (1.23%) | N/A | 0.4207 |
| Thrombocytopenia | 1 (1.61%) | 1 (1.61%) | 5 (6.17%) | N/A | 0.4000 |
| Vomiting | 2 (3.23%) | N/A | 3 (3.70%) | N/A | 0.8816 |
| Diarrhea | 2 (3.23%) | N/A | 2 (2.47%) | N/A | 0.7915 |
| Hepatic dysfunction | 1 (1.61%) | N/A | 1 (1.23%) | N/A | 0.8507 |
| Peripheral neurotoxicity | 3 (4.84%) | N/A | 2 (2.47%) | N/A | 0.5611 |
| Hand-foot syndrome | 3 (4.84%) | N/A | 2 (2.47%) | N/A | 0.5611 |
| Alopecia | 3 (4.84%) | N/A | 2 (2.47%) | N/A | 0.5611 |